メインコンテンツにスキップ

Are Gaps in Your Clinical Pharmacology Program Jeopardizing Your Drug’s Approval?

今日、臨床薬理情報は医薬品添付文書の50%以上を占めています。不完全な臨床薬理学開発プログラムは、審査期間中にスポンサーに重大な問題を引き起こしたり、販売申請の承認可否に影響を与える可能性があります。Efficient clinical pharmacology review of a marketing application requires early and thoughtful consideration of the development plan, timely conduct of … Continued

新薬承認に向けて臨床薬理学的課題を克服するための戦略

今日、臨床薬理情報は医薬品添付文書の50%以上を占めています。不完全な臨床薬理学開発プログラムは、審査期間中にスポンサーに重大な問題を引き起こしたり、販売申請の承認可否に影響を与える可能性があります。Efficient clinical pharmacology review of a marketing application requires early and thoughtful consideration of the development plan, timely conduct of … Continued

Can’t ChatGPT Do That? Practical Applications for AI in Drug Development

While the popularity of tools like ChatGPT have brought AI to the forefront of tech investments, nearly 73% of life science companies still struggle to adopt an appropriate AI technology. Some of the biggest challenges to successful adoption are clearly defined use cases, appropriately trained AI that understands scientific concepts and approachable applications for leveraging … Continued

Access Phoenix anywhere: How to leverage the power of cloud computing to streamline PK workflows

Compared to the Phoenix software installed on local computers, Phoenix Hosted gives research teams much better application performance, flexible access from PC or Mac environments, and comes pre-installed, pre-licensed, and pre-validated. Phoenix Hosted offers scalable hardware to any number of users in a personal workspace for each user. Teams can quickly adopt the latest version … Continued

1 of 1
Powered by Translations.com GlobalLink OneLink Software